Farage threatens vetting company with legal action for ‘stitch up’ June 18, 2024 Reform UK leader Nigel Farage has threatened to sue the company responsible for vetting Reform UK's candidates, accusing the firm of "stitching up" his party.
FCA appoints interim retail banking boss after shake-up at payments regulator June 18, 2024 The Financial Conduct Authority (FCA) has appointed an interim retail banking boss after parachuting in its director to lead the payments watchdog amid industry backlash over new fraud refund rules.
Round two: Water firm seeks to appeal Ofwat penalties decision June 18, 2024 Northumbrian Water is back in court today as it seeks to overturn a ruling in favour of Ofwat decision regarding penalties for supply interruptions
London-listed Litigation Capital Management appoints veteran accountant as CFO June 18, 2024 Litigation Capital Management has appointed David Collins as its new chief financial officer, as Mary Gangemi is set to resign
Revolut adds ‘Revpoints’ and financial market trading tools in bid to become money super app June 18, 2024 Revolut announced two new products, focusing on travel discounts and bond trading, on Tuesday as the fintech looks to diversify its revenue streams and achieve superapp status.
One of Russia’s top food retailers cancels London listing June 18, 2024 O'Key group pulled out of London this morning, after notifying markets about its intention to do so last month.
Supermarkets hope for Euro 2024 boost as Asda and Co-op lose ground June 18, 2024 Asda and the Co-op are the only major supermarket brands in the UK to have lost market share over recent weeks, according to new figures.
Cosmen family pounces on ‘depressed’ share price of National Express owners June 18, 2024 The Cosmen family has upped its stake in the owner of National Express to 21.1 per cent. from 20.2 per cent.
Stablecoin Issuers Are Becoming Major Holders of US Debt June 18, 2024 If stablecoin issuers were a country, they would be just outside the top 10 nation-state holders of US government debt.
Oxford Biomedica issues new shares to secure a £17m investment June 18, 2024 Cell and gene therapy company Oxford Biomedica has announced a near £17m investment which will see it issue new shares to the London Stock Exchange.